Probing Chemical Equilibrium in Frozen Sodium Phosphate Buffer Solution by 31P Solid-State NMR
Source abstract
Abstract
Phosphate buffers are crucial for cryopreservative stability in pharmaceuticals, food processing, biomedical sciences, and biology. However, their freeze concentrates lack quantitative characterization, especially regarding the physicochemical properties of phosphate salt species in equilibrium at subzero temperatures. This study employs 31 P solid-state NMR (ssNMR) to analyze frozen sodium phosphate (NaP) solutions, providing insights into phase composition, ionic strength, and pH. For the first time, we have directly quantified phosphate species in frozen NaP buffer, including crystallized disodium phosphate dodecahydrate (Na 2 HPO 4 ·12H 2 O) content and the concentrations of H 2 PO 4 – and HPO 4 2– in the freeze concentrate. This enabled the calculation of the pH as well as the ionic strength in the freeze concentrate. Trehalose effectively mitigated pH shifts in buffer solutions by preventing the selective crystallization of salt, a spectroscopic phenomenon not previously observed experimentally.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced NMR Techniques and Applications · Chemical Synthesis and Characterization · Zeolite Catalysis and Synthesis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Analytical Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
Department of Pharmaceutics College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States
Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., West Point, Pennsylvania 19486, United States
Funding
University of Minnesota · Merck
References (26)
Show source-provided references
1. 10.1016/j.xphs.2019.10.06210.1016/j.xphs.2019.10.062 ↗
2. 10.1080/1083745070148115710.1080/10837450701481157 ↗
3. 10.1023/A:101218070728310.1023/A:1012180707283 ↗
4. 10.1016/j.jconrel.2020.04.03310.1016/j.jconrel.2020.04.033 ↗
5. 10.1007/s11095-019-2619-210.1007/s11095-019-2619-2 ↗
6. 10.1016/j.trac.2020.11615210.1016/j.trac.2020.116152 ↗
7. 10.1016/j.ssnmr.2022.10179610.1016/j.ssnmr.2022.101796 ↗
8. 10.1080/0570492080194433810.1080/05704920801944338 ↗
9. 10.1021/ja039216210.1021/ja0392162 ↗
10. 10.1073/pnas.040613010210.1073/pnas.0406130102 ↗
11. 10.1126/science.276.5314.93010.1126/science.276.5314.930 ↗
12. 10.1021/ar300358z10.1021/ar300358z ↗
13. 10.1021/acs.molpharmaceut.3c0076410.1021/acs.molpharmaceut.3c00764 ↗
14. 10.1016/S0066-4103(06)60004-510.1016/S0066-4103(06)60004-5 ↗
15. 10.1038/s41596-020-0385-610.1038/s41596-020-0385-6 ↗
16. 10.1016/j.addr.2021.02.00710.1016/j.addr.2021.02.007 ↗
17. 10.1023/A:102344590537210.1023/A:1023445905372 ↗
18. 10.1016/j.xphs.2024.04.01310.1016/j.xphs.2024.04.013 ↗
19. 10.1271/bbb.61.46610.1271/bbb.61.466 ↗
20. 10.1016/j.ijpharm.2019.02.01910.1016/j.ijpharm.2019.02.019 ↗
21. 10.1021/ed078p149910.1021/ed078p1499 ↗
22. 10.1021/ja01333a01810.1021/ja01333a018 ↗
23. 10.1371/journal.pone.004724210.1371/journal.pone.0047242 ↗
24. Heger, D.; Govindarajan, R.; Lu, E.; Ewing, S.; Lay-Fortenbery, A.; Yuan, X.; Veselý, L.; Munson, E.; Gatlin, L.; Hancock, B. Beyond pH: Acid/Base Relationships in Frozen and Freeze-Dried Pharmaceuticals. In Principles and Practices of Lyophilization in Product Development and Manufacturing; Jameel, F., Ed. Springer International Publishing: 2023; pp 39–61.10.1007/978-3-031-12634-5_3 ↗
25. 10.1073/pnas.220676512010.1073/pnas.2206765120 ↗
26. 10.1002/nbm.505710.1002/nbm.5057 ↗